The prevalence of vitamin d deficiency and insufficiency in a hematology-oncology clinic

Clinical Journal of Oncology Nursing

Volumn 12, Issue 1, 2008, Pages 33-35

  Everett, Phyllis C ^a  

^a Lynchburg Hematology Oncology Clinic Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; BONE DENSITY CONSERVATION AGENT; ERGOCALCIFEROL;

BONE DENSITY; DRUG EFFECT; DRUG MONITORING; HUMAN; NEOPLASM; NURSE PRACTITIONER; NURSING ASSESSMENT; ONCOLOGY NURSING; OUTPATIENT DEPARTMENT; PATIENT SELECTION; PREVALENCE; REVIEW; TREATMENT OUTCOME; UNITED STATES; VITAMIN D DEFICIENCY;

AMBULATORY CARE FACILITIES; ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DRUG MONITORING; ERGOCALCIFEROLS; HUMANS; NEOPLASMS; NURSE PRACTITIONERS; NURSING ASSESSMENT; ONCOLOGIC NURSING; PATIENT SELECTION; PREVALENCE; TREATMENT OUTCOME; VIRGINIA; VITAMIN D DEFICIENCY;

EID: 42949162184     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/08.CJON.33-35     Document Type: Article

References (15)

1. Bischoff-Ferrari, H.A., Giovannucci, E., Willett, W.C., Dietrich, T., & Dawson-Hughes, B. (2006). American Journal of Clinical Nutrition, 84(1), 18-28.
2. Boyles, S. (2003). Lack of vitamin D linked to pain. WebMD Medical News. Retrieved August 3, 2006, from http://webmd.com/content/article/78/95751.htm
3. Davis, C. (2007). Vitamin D and cancer: Current Dilemmas, future needs. Retrieved January 1, 2008, from http://dcp.cancer.gov/newsandevents/eventsarchive/20070507-8
4. Dranov, P. (2006, September). The miracle vitamin. Readers Digest, 169(1013), 163-169.
5. Garland, C.F. & Garland, F.C. (1980). Do sunlight and vitamin D reduce the likelihood of colon cancer? International Journal of Epidemiology, 9(3), 227-231.
6. Garland, C.F., Gorham, E.D., Mohr, S.B., Grant, W.B., Giovannucci, E.L., Lipkin, M., et al. (2007). Vitamin D and the prevention of breast cancer: Pooled analysis. Journal of Steroid Biochemistry and Molecular Biology, 103(3), 708-711.
7. Gorham, E.D., Garland, C.F., Garland, F.C., Grant, W.B., Mohr, S.B., Lipkin, M., et al. (2007). Optimal vitamin D status for colorectal cancer prevention: A quantitative metaanalysis. American Journal of Preventive Medicine, 32(3), 210-216.
8. Holick, M.F. (2006). High prevalence of vitamin D inadequacy and implications for health. Mayo Clinic Proceedings, 81(3), 353-373.
9. Lonning, P.F., Geisler, J., Krag, L.E., Erik-stein, B., Bremnes, Y., Hagen, A.I., et al. (2005) Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer. Journal of Clinical Oncology, 23(22), 5126-5137.
10. Lonning, P.F., Geisler, J., Krag, L.E., Lek-kevik, E., Risberg, T., Hegen, A.I., et al. (2006). Vitamin D deficiency: A threat to bone health in breast cancer patients during adjuvant treatment with aromatase inhibitors. Journal of Clinical Oncology, 24 (18 Suppl., Pt. 1), 554.
11. Merck Research Laboratories. (2003). Vitamin D. Merck Manuals Online Medical Library. Retrieved May 5, 2007, from http://www.merck.com/mmhe/sec12/ch154/ch154c.html
12. Plotnikoff, G.A. & Quigley, J.M. (2003). Prevalence of severe hypovitaminosis D in patients with persistent, nonspecifc musculoskeletal pain. Mayo Clinic Proceedings, 78(12), 1463-1470.
13. Snapshots: Shedding light on the controversy over vitamin D. (2006, December). Consultant, 46(14), 1565-1572.
14. Vieth, R. (2006). Critique of the considerations for establishing the tolerable upper intake level for vitamin D: Critical need for revision upward. Journal of Nutrition, 136(4), 1117-1122.
15. Zhou, W., Heist, R.S., Liu, G., Asomaning, K., Neuberg, D.S., Hollis, B.W., et al. (2007). Circulating 25-hydroxy vitamin D levels predict survival in early-stage non-small-cell lung cancer patients. Journal of Clinical Oncology, 25(5), 479-485.